Jefferies Financial Group’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-375,000
| Closed | -$4.33M | – | 1269 |
|
|
2025
Q1 | $4.33M | Hold |
375,000
| – | – | 0.04% | 249 |
|
|
2024
Q4 | $3.18M | Hold |
375,000
| – | – | 0.02% | 375 |
|
|
2024
Q3 | $4.34M | Buy |
375,000
+200,000
| +114% | +$2.32M | 0.03% | 237 |
|
|
2024
Q2 | $2.06M | Buy |
175,000
+140,000
| +400% | +$1.65M | 0.02% | 393 |
|
|
2024
Q1 | $415K | Sell |
35,000
-1,045,000
| -97% | -$12.4M | ﹤0.01% | 833 |
|
|
2023
Q4 | $13.2M | Buy |
1,080,000
+50,000
| +5% | +$613K | 0.09% | 82 |
|
|
2023
Q3 | $9.92M | Hold |
1,030,000
| – | – | 0.09% | 76 |
|
|
2023
Q2 | $9.27M | Sell |
1,030,000
-170,000
| -14% | -$1.53M | 0.08% | 109 |
|
|
2023
Q1 | $9.43M | Hold |
1,200,000
| – | – | 0.08% | 108 |
|
|
2022
Q4 | $8.11M | Buy |
+1,200,000
| New | +$8.11M | 0.06% | 109 |
|